Conversation
What regulators actually want
A former medicines-agency reviewer on timelines, evidence, and the gap between what sponsors submit and what regulators need.
A conversation with a former medicines-agency reviewer on timelines, evidence, and the persistent gap between what sponsors submit and what regulators actually need to say yes.
Full conversation coming soon. Subscribers hear first.
Related across the group
JW van Zyl IncCommercial law for healthcare & life sciences↗
Veltrion LaboratoriesAfrican market entry & regulatory execution↗Share to LinkedIn